Recent cases

A Khan Design Limited v Stephen Horsley & Another [2014] EWHC 3019 (IPEC)21 July 2014Lindsay Lane appeared on behalf of Stephen Horsley in an application to strike out claims for damages and costs made by A Khan Design Limited following a design right trial. Applying the principles in Denton v White, Mr Baldwin QC, struck out the Claimant’s claims for costs and damages on the ground of its failure […]
Eli Lilly v Human Genome Sciences [2014] EWHC 240418 July 2014Michael Tappin QC again acted for HGS in this latest episode of its long-running battle with Eli Lilly. Lilly had challenged the validity of HGS’s patent but failed in the Supreme Court and (on the some outstanding issues) in the Court of Appeal. Lilly then sought a declaration that any SPC granted to HGS based […]
Lilley v Euromoney Institutional Investor Plc & Anor [2014] EWHC 2364 (Ch)16 July 2014Lindsay Lane  appeared for the Chartered Institute of Management Accountants (CIMA), a defendant in one of a number of actions brought by Victor Lilley, a litigant in person. Mr Lilley alleged copyright infringement in relation to articles originally published in journals in the late 1990s on the ground that they had been placed on the internet […]
Rovi Solutions Corporation & Anor v Virgin Media Ltd & Ors [2014] EWHC 2301 (Pat)14 July 2014James Abrahams and Isabel Jamal recently appeared for the Claimants, Rovi Solutions Corporation and United Video Properties Inc., against James Mellor QC and Andrew Lykiardopoulos QC acting for the Defendants, Virgin Media Limited and others. The proceedings related to a European Patent, owned by the Claimant, for live and non-live Video on Demand services. Mr […]
PRCA v. Newspaper Licensing Agency Ltd Case C-360/135 June 2014Andrew Lykiardopoulos QC recently acted for the PRCA in the Supreme Court and reference to the Court of Justice. The case raised the important question of whether copies made on a user’s computer (on screen or in the internet cache) when browsing websites could constitute an infringement of copyright. The Court held that they cannot. […]
Shanks v Unilever [2014] EWHC 1647 (Pat)23 May 2014In Shanks v Unilever [2014] EWHC 1647 (Pat) , Arnold J has dismissed Prof Shanks’ appeal against the IPO’s rejection of his long-running multi-million pound claim for inventor’s compensation against his former employer, Unilever, in respect of patents which he claimed to be of ‘outstanding benefit’ to Unilever. The patents were in for the so-called electrochemical capillary […]
Generics (UK) Ltd (t/a Mylan) v Richter Gedeon Vegyeszeti Gyar RT [2014] EWHC 1666 (Pat)22 May 2014Lindsay Lane  recently appeared as part of Richter Gedeon Vegyeszeti Gyar RT’s legal team defending an invalidity and revocation claim brought by Generics UK Limited. The patent concerned a dosage regimen for use of levonorgestrel as a method of emergency contraception. The claim was brought on the grounds of obviousness and insufficiency. Sales J found […]
Swarovski-Optik KG v Leica Camera AG and Leica Camera Limited [2014] EWCA Civ 63715 May 2014Andrew Lykiardopoulos QC recently appeared in the Court of Appeal for Swarovski, responding to an appeal brought by Leica from the Judgment of Vos J [2013] EWHC 1227 (Pat). The first instance trial concerned a patent owned by Swarovski for the use of an additional strong negative lens in riflescopes to enable a wide field […]
Rovi Solutions Corporation & Anor v Virgin Media Ltd & Ors [2014] EWHC 1559 (Pat)15 May 2014Members of Chambers recently appeared for both sides in one of the listed patent actions between Rovi and Virgin Media. Richard Meade QC and Henry Ward appeared for Rovi. James Mellor QC and Andrew Lykiardopoulos appeared for Virgin Media. The dispute concerned interactive television services (in particular the Virgin Media “Red Button” service). Rovi claimed […]
Actavis UK Limited and others v Eli Lilly & Company [2014] EWHC 1511 (Pat)15 May 2014Richard Meade QC and Isabel Jamal, together with Thomas Raphael, represented Actavis in its landmark win against Eli Lilly. Judgment was handed down on 15 May 2014 in the long-running patent dispute between Actavis and Eli Lilly regarding Lilly’s patent relating to the use of the anti-cancer drug pemetrexed disodium with vitamin B12 and (optionally) […]